Fate Share Price
NASDAQ: FATE | Micro Cap | HealthcareFate Stock Performance
Fate Share Price Today
As of 22 November 2026, Fate Therapeutics, Inc.'s share price is $0.92. The stock opened at $1.01, compared to its previous close of $1.02. During today's trading session, Fate Therapeutics, Inc.'s share price traded between $0.90 and $1.02, with an average price of $0.96. Over the past 52 weeks, the stock has recorded a high of $3.23 and a low of $0.90. In terms of performance, Fate Therapeutics, Inc.'s share price has declined by 67.44% over the last six months and is down 18.54% on a year-on-year basis.
Fate Share Price Chart
Fate Quarterly Profit & Loss
All figures in USD
Fate Annual Profit & Loss
All figures in USD
Fate Balance Sheet
All figures in USD Million
Fate Cash Flow
All figures in USD Million
About Fate
Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. The company is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.
Fate Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Nov 2026 | $2.11 | $0.92 | -56.08% |
Oct 2026 | $2.36 | $2.09 | -11.81% |
Sep 2026 | $2.38 | $2.37 | -6.32% |
Aug 2026 | $2.39 | $2.53 | +3.69% |
Jul 2026 | $2.67 | $2.44 | -10.13% |
Jun 2026 | $2.69 | $2.71 | -4.40% |
May 2026 | $1.25 | $2.84 | +127.20% |
Apr 2026 | $1.23 | $1.25 | +3.73% |
Mar 2026 | $1.44 | $1.21 | -18.58% |
Feb 2026 | $1.17 | $1.48 | +24.37% |
Jan 2026 | $1.00 | $1.19 | +20.93% |
Dec 2025 | $1.09 | $0.98 | -13.30% |